CHCT

In the past six months, CHCT has increased its quarterly dividends, with the latest dividend at $0.48 per share for Q1 2026. CHCT announced its Q1 2026 earnings, reporting a net income of $2.5 million ($0.07 per diluted share) and total revenue of $31.5 million, surpassing expectations, while the EPS missed analysts' consensus estimates. CHCT announced results for the three months ended December 31, 2025, reporting net income of approximately $14.4 million (or $0.51 per diluted share). The company acquired an inpatient rehabilitation facility in Florida for $28.5 million and disposed of three buildings for $31.6 million in Q4 2025. CHCT's stock has increased by 7.8% since the beginning of 2026 and has outperformed the S&P500 Index by +20.22%. Some analyses have raised concerns about CHCT's underlying fundamentals, suggesting that its true AFFO might be overstated due to aggressive add-backs, leading to a high payout ratio and potentially unsustainable dividend.